Healthcare Industry News: INBONE
News Release - August 17, 2009
Wright Medical Group, Inc. Introduces CORETRAK Articulating External Fixator for Foot SurgeryARLINGTON, Tenn.--(HSMN NewsFeed)--Wright Medical Group, Inc. (NASDAQ: WMGI ), a global orthopaedic medical device company, announced the launch of its patent pending CORETRAK(TM) Articulating External Fixator. The CORETRAK(TM) articulating fixator design is well-suited for challenging fixation cases of the foot, such as those involving diabetic patients.
The goal of Wright’s CORETRAK(TM) articulating fixator design is to simplify the procedure for the surgeon, the patient, and hospital staff. The device also addresses a growing need for minimally invasive solutions that respect the body’s natural ability to heal, which is particularly important for the growing population of diabetics who are already at a high risk for surgical complications.
Robert D. Santrock, M.D. of Midlands Orthopedics in Columbia, South Carolina, specializes in the care and treatment of the diabetic foot and its associated complications. Dr. Santrock expressed, “The new articulating CORETRAK(TM) fixator will take external fixation to a new level with its low profile, patient-friendly design and adaptability to multiple conditions in the foot.” His associate William C. James, III, M.D. noted, “External fixation is particularly useful for the diabetic foot due to its ability to stabilize bones while avoiding areas with open wounds and/or infection. I find it a useful tool for reconstructing the foot in a high risk patient.”
Bradley M. Lamm, D.P.M., Head of Foot and Ankle Surgery, International Center for Limb Lengthening of the Rubin Institute for Advanced Orthopedics at Sinai Hospital in Baltimore, Maryland further commented, “I am looking forward to this new technology for the treatment of arthritis in the big toe joint. The CORETRAK(TM) articulating fixator has specific design features to address pain and stiffness in the toe joint and may save a patient from a joint replacement or fusion.”
Wright’s CORETRAK(TM) Articulating Fixator is provided in a sterile packaged procedure kit to save surgical facilities time and expense of cleaning and sterilizing. The kits may also be useful for military and emergency operations where time is critical. The new CORETRAK(TM) fixator will be made available immediately in the U.S. through Wright’s specialized foot and ankle sales force, and in select countries outside the U.S. through its direct and distributor-based sales representatives.
The CORETRAK(TM) fixator is the latest addition to Wright’s market-leading suite of products for foot and ankle surgeons. These include the CHARLOTTE(TM) family of reconstructive implants, DARCO(R) locked plating systems, ORTHOLOC(TM) variable angle plates, the BIOARCH(R) subtalar implant, CANCELLO-PURE(R) and BIOFOAM(TM) osteotomy wedge systems, ENDO-FUSE(TM) implants, DART-FIRE(TM) small screw systems, GRAFTJACKET(R) regenerative tissue matrix, and the INBONE(R) total ankle.
Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the company’s website at www.wmt.com.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company’s filings with the Securities and Exchange Commission (including the Company’s annual report on Form 10-K for the year ended December 31, 2008, under the heading, “Risk Factors”), which could cause the Company’s actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.
Source: Wright Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.